Eleanor Elstein

2.5k total citations
24 papers, 898 citations indexed

About

Eleanor Elstein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Transplantation. According to data from OpenAlex, Eleanor Elstein has authored 24 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 6 papers in Transplantation. Recurrent topics in Eleanor Elstein's work include Transplantation: Methods and Outcomes (10 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Cardiomyopathy and Myosin Studies (5 papers). Eleanor Elstein is often cited by papers focused on Transplantation: Methods and Outcomes (10 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Cardiomyopathy and Myosin Studies (5 papers). Eleanor Elstein collaborates with scholars based in Canada, United States and Saudi Arabia. Eleanor Elstein's co-authors include Harry Haber, François Charbonneau, Todd J. Anderson, Jeffrey Barkun, M Cantarovich, Jean‐Guy Besner, Rolf Loertscher, Benoît de Varennes, Marcelo Cantarovich and Alan Barkun and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Transplantation.

In The Last Decade

Eleanor Elstein

22 papers receiving 865 citations

Peers

Eleanor Elstein
Carmen S. Amuchastegui Italy
Anita Mehrotra United States
F.T.M. Huysmans Netherlands
Augusto Antonello Italy
Nicola Joss United Kingdom
C Zehnder Switzerland
Annalisa Teutonico Italy
Gisela Weihrauch Austria
Ignacio Sánchez‐Lázaro Spain
Marinus H. de Keijzer Netherlands
Carmen S. Amuchastegui Italy
Eleanor Elstein
Citations per year, relative to Eleanor Elstein Eleanor Elstein (= 1×) peers Carmen S. Amuchastegui

Countries citing papers authored by Eleanor Elstein

Since Specialization
Citations

This map shows the geographic impact of Eleanor Elstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor Elstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor Elstein more than expected).

Fields of papers citing papers by Eleanor Elstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleanor Elstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor Elstein. The network helps show where Eleanor Elstein may publish in the future.

Co-authorship network of co-authors of Eleanor Elstein

This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor Elstein. A scholar is included among the top collaborators of Eleanor Elstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor Elstein. Eleanor Elstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michel, René P., et al.. (2021). Case report: multimodality imaging to diagnose cardiac diffuse large B-cell lymphoma. European Heart Journal - Case Reports. 5(5). ytab172–ytab172. 1 indexed citations
2.
3.
4.
Assimes, Themistocles L., Eleanor Elstein, Adrian Langleben, & Samy Suissa. (2008). Long‐term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiology and Drug Safety. 17(11). 1039–1049. 56 indexed citations
5.
Bourgault, Chantal, Eleanor Elstein, Marc Baltzan, Jacques Le Lorier, & Samy Suissa. (2001). Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use. Pharmacoepidemiology and Drug Safety. 10(4). 287–294. 2 indexed citations
6.
Anderson, Todd J., Eleanor Elstein, Harry Haber, & François Charbonneau. (2000). Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). Journal of the American College of Cardiology. 35(1). 60–66. 296 indexed citations
7.
Cantarovich, Marcelo, Mackenzie Quantz, Eleanor Elstein, et al.. (2000). Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction. Transplantation Proceedings. 32(2). 446–448. 14 indexed citations
8.
Elstein, Eleanor, et al.. (1999). C677T gene mutation in methylenetetrahydrofolate reductase as a risk factor for cardiac allograft vasculopathy. Transplantation Proceedings. 31(1-2). 99–99. 3 indexed citations
9.
10.
Cantarovich, Marcelo, et al.. (1999). Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction. Transplantation Proceedings. 31(1-2). 79–79. 1 indexed citations
11.
Cantarovich, M, Eleanor Elstein, Benoît de Varennes, & Jeffrey Barkun. (1999). CLINICAL BENEFIT OF NEORAL DOSE MONITORING WITH CYCLOSPORINE 2-HR POST-DOSE LEVELS COMPARED WITH TROUGH LEVELS IN STABLE HEART TRANSPLANT PATIENTS1. Transplantation. 68(12). 1839–1842. 129 indexed citations
12.
Gilfix, Brian M., Marcelo Cantarovich, & Eleanor Elstein. (1999). Relationship Between Cyclosporine, Creatinine, And Homocysteine In Cardiac Transplant Patients.. Transplantation. 67(7). S108–S108. 4 indexed citations
13.
Cantarovich, M, et al.. (1999). Clinical benefit of neoral dose monitoring with cyclosporine 2-hour peak levels compared to trough levels in stable heart transplant patients. The Journal of Heart and Lung Transplantation. 18(1). 78–78. 2 indexed citations
14.
Cantarovich, M, Jean‐Guy Besner, Jeffrey Barkun, Eleanor Elstein, & Rolf Loertscher. (1998). Two‐hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy1. Clinical Transplantation. 12(3). 243–249. 118 indexed citations
15.
Cantarovich, Marcelo, Jean‐Guy Besner, Alan Barkun, Eleanor Elstein, & Rolf Loertscher. (1998). Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy.. PubMed. 12(3). 243–9. 151 indexed citations
16.
17.
Brugada, Ramón, Weston M. Kelsey, Marcel E. Lechin, et al.. (1997). Role of Candidate Modifier Genes on the Phenotypic Expression of Hypertrophy in Patients with Hypertrophic Cardiomyopathy. Journal of Investigative Medicine. 45(9). 542–551. 77 indexed citations
18.
19.
Elstein, Eleanor. (1995). The molecular genetics of hypertrophic cardiomyopathy. Current Opinion in Cardiology. 10(3). 293–298.
20.
Elstein, Eleanor. (1992). The genetic basis of hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology. 24(12). 1471–1477. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen S. Amuchastegui Breakdown of academic impact, for papers by Anita Mehrotra Breakdown of academic impact, for papers by F.T.M. Huysmans Breakdown of academic impact, for papers by Augusto Antonello Breakdown of academic impact, for papers by Nicola Joss Breakdown of academic impact, for papers by C Zehnder Breakdown of academic impact, for papers by Annalisa Teutonico Breakdown of academic impact, for papers by Gisela Weihrauch Breakdown of academic impact, for papers by Ignacio Sánchez‐Lázaro Breakdown of academic impact, for papers by Marinus H. de Keijzer
Rankless by CCL
2026